Literature DB >> 20600743

Temporary reduction of distortion product otoacoustic emissions (DPOAEs) immediately following auditory brainstem response (ABR).

Anand N Mhatre1, Bobby Tajudeen, Elena M Welt, Christopher Wartmann, Glenis R Long, Anil K Lalwani.   

Abstract

The hearing status of an experimental animal is typically assessed in the laboratory setting by the combined use of auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAEs), carried out in succession, with the former assay preceding the latter. This study reports a cautionary finding that the use of this accepted regimen yields a reduced DPOAE response. When the DPOAEs were performed after ABR testing, transient reduction of the DPOAE amplitudes was observed at all frequencies in both the inbred, C57/B6 and FVB/N, and the outbred, SW mouse strains. DPOAEs were reduced post-ABR in multiple mouse strains which suggests that this finding is not strain-specific but a general consequence of the preceding ABR analysis. The reduction in DPOAE was temporary: when re-tested at one hour, DPOAE amplitudes recovered to pre-ABR levels. In contrast to the ABR's impact on DPOAE response, ABR thresholds were not altered or reduced when preceded immediately by DPOAE measurements. The molecular alterations underlying the ABR-induced transient reduction of DPOAE remain to be determined. To investigate the potential role of reactive oxygen species in post-ABR DPOAE reduction, transgenic mice over-expressing SOD1, the cytoplasmic enzyme critical for removal of superoxide radicals were subjected to the same auditory testing regimen. Similar to their wild type littermates, the SOD1 transgenic mice also demonstrated post-ABR DPOAE reduction, and thus do not support a role for superoxide radicals in transient reduction of DPOAE. While toxic noise exposure is known to negatively impact OAE, transient decrease in DPOAE levels following standard ABR assay has not been previously described. A practical outcome from this study is a recommendation for reversal of the traditional order for carrying out auditory tests, with the OAE measurements preceding ABR assessment, thus ensuring that the DPOAE response is unaffected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600743      PMCID: PMC2935313          DOI: 10.1016/j.heares.2010.06.012

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  29 in total

1.  Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise.

Authors:  Anjali Desai; David Reed; Alex Cheyne; Scott Richards; Deepak Prasher
Journal:  Noise Health       Date:  1999       Impact factor: 0.867

2.  Distortion-Product Otoacoustic Emissions as a Screening Tool for Noise-Induced Hearing Loss.

Authors:  Lynne Marshall; Judy A. Lapsley Miller; Laurie M. Heller
Journal:  Noise Health       Date:  2001       Impact factor: 0.867

3.  Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss.

Authors:  S H Sha; G Zajic; C J Epstein; J Schacht
Journal:  Audiol Neurootol       Date:  2001 May-Jun       Impact factor: 1.854

4.  Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils.

Authors:  K C Sie; S J Norton
Journal:  Otolaryngol Head Neck Surg       Date:  1997-06       Impact factor: 3.497

5.  Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D.

Authors:  F Di Palma; R H Holme; E C Bryda; I A Belyantseva; R Pellegrino; B Kachar; K P Steel; K Noben-Trauth
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

6.  A major gene affecting age-related hearing loss in C57BL/6J mice.

Authors:  K R Johnson; L C Erway; S A Cook; J F Willott; Q Y Zheng
Journal:  Hear Res       Date:  1997-12       Impact factor: 3.208

7.  Cu/Zn SOD deficiency potentiates hearing loss and cochlear pathology in aged 129,CD-1 mice.

Authors:  S L McFadden; D Ding; R F Burkard; H Jiang; A G Reaume; D G Flood; R J Salvi
Journal:  J Comp Neurol       Date:  1999-10-11       Impact factor: 3.215

8.  ABR and DPOAE detection of cochlear damage by gentamicin.

Authors:  Y Shi; W H Martin
Journal:  J Basic Clin Physiol Pharmacol       Date:  1997

9.  Generation and characterization of mice with Myh9 deficiency.

Authors:  Anand N Mhatre; Yan Li; Nitin Bhatia; Kevin H Wang; Graham Atkin; Anil K Lalwani
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

10.  Effect of SOD1 overexpression on age- and noise-related hearing loss.

Authors:  Donald E Coling; Kenneth C Y Yu; David Somand; Bulent Satar; Uma Bai; Ting-Ting Huang; Michael D Seidman; Charles J Epstein; Anand N Mhatre; Anil K Lalwani
Journal:  Free Radic Biol Med       Date:  2003-04-01       Impact factor: 7.376

View more
  4 in total

1.  Paired measurements of cochlear function and hair cell count in Dutch-belted rabbits with noise-induced hearing loss.

Authors:  Hariprakash Haragopal; Ryan Dorkoski; Holly M Johnson; Mark A Berryman; Soichi Tanda; Mitchell L Day
Journal:  Hear Res       Date:  2019-11-15       Impact factor: 3.208

2.  Pegylated Insulin-Like Growth Factor 1 attenuates Hair Cell Loss and promotes Presynaptic Maintenance of Medial Olivocochlear Cholinergic Fibers in the Cochlea of the Progressive Motor Neuropathy Mouse.

Authors:  Linda Bieniussa; Baran Kahraman; Johannes Skornicka; Annemarie Schulte; Johannes Voelker; Sibylle Jablonka; Rudolf Hagen; Kristen Rak
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

3.  Long term changes to auditory sensitivity following blast trauma in mice.

Authors:  Kali Burke; Senthilvelan Manohar; Micheal L Dent
Journal:  Hear Res       Date:  2021-02-12       Impact factor: 3.208

4.  Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-cyclodextrin.

Authors:  Mark A Crumling; Liqian Liu; Paul V Thomas; Jennifer Benson; Ariane Kanicki; Lisa Kabara; Karin Hälsey; David Dolan; R Keith Duncan
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.